Jubilant Ingrevia's Stock Sees -5.23% Decline, Underperforms Market on October 24, 2024

Jubilant Ingrevia, a midcap pharmaceutical and drug company, saw a decline of -5.23% in its stock price on October 24, 2024. This underperformance was reflected in the stock's day's low of Rs 669, which was a decrease of -5.51% from the previous day's closing price.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the current stock call for Jubilant Ingrevia is 'Hold'. This is based on the stock's performance today, where it underperformed the sector by -5.92%. However, it is important to note that the stock's moving averages are still higher than the 100 day and 200 day averages, indicating a positive trend in the long term.

In comparison to the overall market performance, Jubilant Ingrevia's stock saw a decline of -4.52% on the same day, while the Sensex only saw a decrease of -0.09%. This shows that the stock's performance was significantly lower than the market's.

Looking at the stock's performance over the past month, Jubilant Ingrevia has seen a decline of -10.88%, while the Sensex has only decreased by -5.78%. This further highlights the underperformance of the stock in the current market.

Overall, Jubilant Ingrevia's stock has seen a decline in its price and underperformed in the market. However, it is important to consider the stock's long term trend and moving averages before making any investment decisions. Investors are advised to do their own research and consult with a financial advisor before making any decisions.